← All stocks

Option Care Health, Inc.

OPCH No buying or selling
CIK 0001014739 #1619 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

20 insiders · 0 transactions
14.3×

John C. Rademacher holds 14.3 times base salary in stock. $14.38M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what John C. Rademacher last reported holding, valued at $20.69, the price Common Stock was last bought or sold at on the open market here, on 7 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
RADEMACHER JOHN CHARLES
Chief Executive Officer
695,152
$14.38M
+16.6%
KRAEMER HARRY M JANSEN JR
Director
471,076
$9.75M
+66.3%
SHAPIRO MICHAEL H.
Chief Financial Officer
311,933
$6.45M
+26.1%
Whitworth Luke
Chief Operating Officer
169,589
$3.51M
+43.9%
GOLDING DAVID W
Director
116,525
$2.41M
+8.8%
Sethna Meenal
Chief Financial Officer
98,337
$2.03M
SULLIVAN TIMOTHY P
Director
87,216
$1.80M
+319.0%
Smyser Collin
GC & Corporate Secretary
75,012
$1.55M
+79.1%
Grashoff Christopher L.
Chief Growth Officer
44,092
$912.13K
+67.8%
Bhatia Prateek
EVP Sp Sales & Solutions
39,795
$823.24K
Bavaro Michael
Chief Human Resources Officer
33,249
$687.82K
−23.4%
Bierbower Elizabeth D
Director
32,871
$680.00K
+74.5%
Deckmann Natasha
Director
32,002
$662.02K
+94.0%
Maggio Nicole
Chief Accounting Officer
28,489
$589.35K
+89.2%
BETTEN ELIZABETH QUADROS
Director
26,373
$545.58K
+23.6%
Adewunmi Femi
Chief Medical Officer
25,314
$523.67K
+156.6%
Wright Norman L.
Director
24,498
$506.79K
+247.2%
BRANDT ERIC
Director
21,999
$455.09K
+313.1%
Bodem Barbara W.
Director
21,087
$436.22K
+198.9%
Pate R Carter
Director
20,620
$426.56K
−42.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 14 Nov 2016